WHEN AND HOW SHOULD ANABOLIC STEROID THERAPY BE USED?
D045930:Anabolic Agents; D000856:Anorexia Nervosa; D001859:Bone Neoplasms; D001943:Breast Neoplasms; D003348:Cortisone / Q000633:toxicity*; D006801:Humans; D006980:Hyperthyroidism; D007239:Infections; D007410:Intestinal Diseases; D007674:Kidney Diseases; D008107:Liver Diseases; D009362:Neoplasm Metastasis; D009369:Neoplasms; D010024:Osteoporosis; D011183:Postoperative Complications; D011506:Proteins / Q000378:metabolism*; D013256:Steroids; D013851:Thinness; D014116:Toxicology; D014511:Uremia
D045930:Anabolic Agents; D011506:Proteins; D013256:Steroids; D003348:Cortisone
ANABOLIC STEROIDS; ANOREXIA NERVOSA; BONE NEOPLASMS; BREAST NEOPLASMS; CORTISONE TOXICOLOGY; HYPERTHYROIDISM; INFECTION; INTESTINAL DISEASES; KIDNEY DISEASES; LIVER DISEASES; NEOPLASM METASTASIS; OSTEOPOROSIS; POSTOPERATIVE COMPLICATIONS; PROTEIN METABOLISM; THINNESS; TOXICOLOGIC REPORT; UREMIA